Adma Biologics, Inc. financial data

Symbol
ADMA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
C/O Adma Biologics, Inc., 465 State Route 17, Ramsey, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
R&R ACQUISITION VI, INC (to 2/21/2012)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 602 % -10.5%
Quick Ratio 366 % -10.4%
Debt-to-equity 104 % -21%
Return On Equity 38.4 %
Return On Assets 18.8 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 236M shares +4.61%
Common Stock, Shares, Outstanding 236M shares +4.61%
Entity Public Float 794M USD +113%
Common Stock, Value, Issued 24K USD +6.21%
Weighted Average Number of Shares Outstanding, Basic 235M shares +4.13%
Weighted Average Number of Shares Outstanding, Diluted 245M shares +4.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 383M USD +63.4%
Cost of Revenue 196M USD +20.5%
Research and Development Expense 1.87M USD -52.5%
Operating Income (Loss) 115M USD +8471%
Nonoperating Income (Expense) -41.5M USD -71.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 36.7M USD +1333%
Income Tax Expense (Benefit) 5.22M USD
Net Income (Loss) Attributable to Parent 68.1M USD +1300%
Earnings Per Share, Basic 0.29 USD/shares +1400%
Earnings Per Share, Diluted 0.28 USD/shares +1400%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 86.7M USD +16.9%
Accounts Receivable, after Allowance for Credit Loss, Current 50.1M USD +60.1%
Inventory, Net 172M USD +5.32%
Assets, Current 318M USD +16.3%
Property, Plant and Equipment, Net 53.7M USD -2.04%
Operating Lease, Right-of-Use Asset 8.9M USD -8.78%
Intangible Assets, Net (Excluding Goodwill) 485K USD +1.7%
Goodwill 3.53M USD +0.01%
Assets 391M USD +11.9%
Accounts Payable, Current 16M USD +47.6%
Contract with Customer, Liability, Current 143K USD +0.12%
Liabilities, Current 44.9M USD +7.29%
Operating Lease, Liability, Noncurrent 8.87M USD -11%
Other Liabilities, Noncurrent 375K USD -13.7%
Liabilities 159M USD -19.7%
Retained Earnings (Accumulated Deficit) -420M USD +13.9%
Stockholders' Equity Attributable to Parent 232M USD +53.1%
Liabilities and Equity 391M USD +11.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.22M USD +84.9%
Net Cash Provided by (Used in) Financing Activities -1.45M USD -123%
Net Cash Provided by (Used in) Investing Activities -2.36M USD -21.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 236M shares +4.61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.03M USD +65.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 86.7M USD +16.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 584K USD -87.4%
Deferred Tax Assets, Valuation Allowance 101M USD +4.86%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 101M USD +4.86%
Payments to Acquire Property, Plant, and Equipment 2.35M USD +20.7%
Lessee, Operating Lease, Liability, to be Paid 15.5M USD -12.7%
Property, Plant and Equipment, Gross 86.1M USD +7.78%
Operating Lease, Liability, Current 1.19M USD +21.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.16M USD -8.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.42M USD +3.32%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.4M USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.04M USD -3.55%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.09M USD +2.32%
Operating Lease, Payments 2.4M USD +4.35%
Additional Paid in Capital 652M USD +1.93%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 550K USD -23.1%
Depreciation, Depletion and Amortization 7.6M USD +1.33%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 22.7M USD +3.07%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%